Activation of HER Family Signaling as a Mechanism of Acquired Resistance to ALK Inhibitors in EML4-ALK–Positive Non–Small Cell Lung CancerJunko Tanizaki, Kazuhiko Nakagawa, Takafumi Okabe et al.|Clinical Cancer Research|2012Cited by 156
Role of ERK-BIM and STAT3-Survivin Signaling Pathways in ALK Inhibitor–Induced Apoptosis in EML4-ALK–Positive Lung CancerKen Takezawa, Kazuhiko Nakagawa|Clinical Cancer Research|2011Cited by 141
RETRACTED ARTICLE: Identification of thymidylate synthase as a potential therapeutic target for lung cancerKen Takezawa, Kazuhiko Nakagawa|British Journal of Cancer|2010Cited by 35